Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Single-cell resolution reveals cell type, targets, for neuroblastoma

Feb. 8, 2021

Scenic Immunology synthesizes new QC and/or QPCTL inhibitors

Feb. 8, 2021

Pfizer presents new TLR agonists

Feb. 8, 2021

Ono Pharmaceutical divulges KDM5A inhibitors

Feb. 8, 2021

China NMPA approves phase III trial of orelabrutinib with R-CHOP for MCL

Feb. 5, 2021

CEACAM7 is a therapeutic target for CART therapy in PDAC

Feb. 5, 2021

University of South Australia discovers new candidate for glioblastoma

Feb. 5, 2021

New Aurora kinase inhibitors described by Wigen Biomedicine Technology

Feb. 5, 2021

FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations

Feb. 4, 2021

Erlotinib plus anlotinib shows promise in EGFR-mutated NSCLC

Feb. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.